NCT05499507 The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
| NCT ID | NCT05499507 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Temple University |
| Condition | Pregnancy Related |
| Study Type | INTERVENTIONAL |
| Enrollment | 432 participants |
| Start Date | 2023-01-24 |
| Primary Completion | 2027-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 432 participants in total. It began in 2023-01-24 with a primary completion date of 2027-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching goal of our proposal is to reduce disparities in perinatal cardiovascular disease risk factors among Black women utilizing a community-driven, social ecological framework.
Eligibility Criteria
Inclusion Criteria: * age ≥18 years * baseline BMI ≥30 kg/m2 and/or diagnosis of HTN (≥130/80 x 2) * gestational age \<24 weeks by last menstrual period * smartphone ownership * self-identification as Black or African American
Contact & Investigator
Sharon J Herring, MD, MPH
PRINCIPAL INVESTIGATOR
Temple University, Philadelphia, Pennsylvania, United States, 19140
Frequently Asked Questions
Who can join the NCT05499507 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05499507 currently recruiting?
Yes, NCT05499507 is actively recruiting participants. Contact the research team at sharon.herring@temple.edu for enrollment information.
Where is the NCT05499507 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT05499507 clinical trial?
NCT05499507 is sponsored by Temple University. The principal investigator is Sharon J Herring, MD, MPH at Temple University, Philadelphia, Pennsylvania, United States, 19140. The trial plans to enroll 432 participants.